Sandoz

News

Sandoz adds 10 biosimilars through $322m Henlius deal

Sandoz is set to add up to 10 new biosimilar assets to its portfolio under a new collaboration deal with China’s Shanghai Henlius Biotech.

News

Sandoz will pay another $480m to settle US antitrust suits

Sandoz has reached a settlement in the US that, if approved, could lay to rest years of litigation over price-fixing of generic medicines.

News

Trump sets course for 100%, then 200%, tariffs on generics

Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.

Patients

pharmaphorum podcast Episode 263, Rebecca Guntern - Sandoz

Biosimilars & patient access independent of geographies or s...

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

News

A pregnant woman with her hands forming a heart shape over her bump, wearing a beige sweater

NICE recommends wider use of MS drug natalizumab via NHS

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis.

Market Access

Sandoz adds 10 biosimilars through $322m Henlius deal

Sandoz will pay another $480m to settle US antitrust suits

Trump sets course for 100%, then 200%, tariffs on generics

Biosimilars & patient access independent of geographies or s...

NICE recommends wider use of MS drug natalizumab via NHS

Inside Sandoz: How women leaders are driving sustainability ...

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

Sandoz

Editor's Picks